Home > Resources > Whitepapers > Boosting R&D Productivity With Pooled CRISPR Screening

Boosting R&D Productivity With Pooled CRISPR Screening

June 23, 2019

Pooled screening is a valuable problem-solving and cost-reduction asset at a time when pressure to conduct focused, productive pharmaceutical R&D is more intense than ever. With the emergence of CRISPR gene-editing technology, pooled screens are becoming an essential component of drug discovery and development in the age of functional genomics.

Spotlight

Nanotech Innovations, LLC

Located in Oberlin, Ohio, Nanotech Innovations (NTI) is at the forefront of nanotechnology research in Northern Ohio. The injection CVD system at the core of our product line was originally investigated at NASA Glenn Research Center. We recognize the demand for a reliable and affordable source of high purity carbon nanotubes. Our single-step process and instrumentation deliver nanotubes with low residual catalyst and virtually no amorphous carbon impurities. The Nanotech Innovations SSP-354 is a benchtop system that provides convenient access to exciting nanomaterials for education, research and product development.

OTHER WHITEPAPERS

2022 Global Life Sciences Outlook

whitePaper | January 7, 2022

While valuations for the life sciences sector in this past year have been mixed, the underlying performance and outlook for the sector is healthy

Next-Generation Technology, Procedures, and Products Facilitate Biopreservation Best Practices for Cellular Therapies.

whitePaper | August 19, 2022

The quality of procedures and products used for preparing, transporting and storing cells at cryogenic temperatures have a direct impact on post-thaw viability and functionality, as well as the consistency and reliability of biological agents from a Quality perspective.

Cell Lysate Sample Handling with Simoa Bead-Based Assays

whitePaper | November 12, 2019

This document describes a novel Quanterix lysate diluent for running lysate samples with Simoa assays diluent.

The A to Z of microarrays evolution of a revolutionary solution

whitePaper | May 27, 2023

The Human Genome Project was a monumental effort over more than a decade to determine the human DNA sequence and analyze genetic variation among individuals. The hope was that, armed with this understanding, phenotypic differences would be explainable by genetic variation, and health benefits could follow.